Mechanisms of decreased Vitamin D 1α-hydroxylase activity in prostate cancer cells

Vitamin D

1979 • 3,814 citations

Methods of tissue engineering

2002 • 531 citations

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland).

2000 • 489 citations

Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.

1998 • 360 citations

Vitamin D and prostate cancer: a prediagnostic study with stored sera.

1993 • 357 citations

New insights into the mechanisms of vitamin D action

2003 • 323 citations

Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition.

2001 • 216 citations

Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.

1998 • 214 citations

Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis.

2003 • 209 citations

Vitamin D and Prostate Cancer

2004 • 192 citations

Expression of 25-Hydroxyvitamin D3-1α-Hydroxylase in the Human Kidney

1999 • 183 citations

25-Hydroxyvitamin D₃-1α-Hydroxylase Expression in Normal and Pathological Parathyroid Glands

2002 • 180 citations

Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression

2003 • 180 citations

25-Hydroxy-Vitamin D Metabolism in Human Colon Cancer Cells during Tumor Progression

2001 • 139 citations

Prostatic 25‐hydroxyvitamin D‐1α‐hydroxylase and its implication in prostate cancer

2003 • 139 citations

25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.

2000 • 138 citations

High‐dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma

2003 • 125 citations

Going malignant: the hypoxia‐cancer connection in the prostate

2002 • 118 citations

25-Hydroxyvitamin D-1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer

2002 • 111 citations

Vitamin D and prostate cancer: biologic interactions and clinical potentials.

1998 • 103 citations

Vitamin D Metabolism

1984 • 97 citations

Vitamin D

2013 • 93 citations

High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects.

1989 • 83 citations

The Mechanism of 1,25-Dihydroxyvitamin D3Autoregulation in Keratinocytes

2002 • 71 citations

Novel Gene Mutations in Patients with 1α-Hydroxylase Deficiency That Confer Partial Enzyme Activityin Vitro

2002 • 71 citations

Intracellular Vitamin D Binding Proteins: Novel Facilitators of Vitamin D-Directed Transactivation

2000 • 65 citations

The 25-Hydroxyvitamin D 1α-Hydroxylase

2005 • 57 citations

25-Hydroxyvitamin D3-1 -Hydroxylase Expression in Normal and Pathological Parathyroid Glands

2002 • 53 citations

Mechanism of action of superactive vitamin D analogs through regulated receptor degradation

2000 • 49 citations

Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D(3) 1,alpha-hydroxylase (CYP 27B1) in human malignant glioma.

2001 • 43 citations

Vitamin D and Prostate Cancer

1999 • 43 citations

Chemotherapy for hormone-refractory prostate cancer: Beauty is in the eye of the beholder

2000 • 33 citations

Vitamin D and prostate cancer

2002 • 32 citations

Vitamin D

2001 • 27 citations

Novel Gene Mutations in Patients with 1 -Hydroxylase Deficiency That Confer Partial Enzyme Activity in Vitro

2002 • 21 citations

Intracellular Vitamin D Binding Proteins: Novel Facilitators of Vitamin D-Directed Transactivation

2000 • 16 citations

Epithelial Cell Culture

2002 • 4 citations

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer

2003 • 4 citations